Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

Clinical trial NCT01718899 · COMPLETED

Trial details

NCT number: NCT01718899
Sponsor: OncoPep, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Smoldering Multiple Myeloma

Start date: 2012-11-01
Primary completion: 2016-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.